Xie et al. (2014) believed that ARID1A depletion could promote CRC cell proliferation, enhance chemoresistance, and inhibit cell apoptosis by regulating the activity of the Akt signaling pathway. This evidence concerns the gene AKT1 and colorectal carcinoma.